Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

• Conditions: Endometrial Cancer; Colon Cancer

• Registration Number: NCT03322176
• Lead Sponsor: Data Collection Analysis Business Management

Brief Summary

Increase surveillance for LYNCH Syndrome

Detailed Description

The purpose of this minimal risk, observational survey is to increase surveillance for Lynch Syndrome (hereditary non-polyposis colon cancer), Colorectal, and Endometrial cancer, also to determine targeted risk-reducing and preventative strategies.

Study Timeline

• Study Start: 2017-10-17
• Study First Submitted: 2017-10-24
• Study First Submitted QC: 2017-10-25
• Study First Posted: 2017-10-26
• Status Verified: 2019-01
• Last Update Submitted: 2019-01-22
• Last Update Posted: 2019-01-23
• Primary Completion: 2020-10-17
• Study Completion: 2020-11-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Must be a Medical Practitioner

  • Medical Doctor (MD)
  • Doctor of Osteopathic (DO)
  • Physician Assistant (PA)
  • Advanced Practice Registered Nurse (APRN)
  • Nurse Practitioner (NP)

• Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history.

Exclusion Criteria

• Government-funded insurance data cannot be included in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Provider Structures and Processes	36 months	Plan of Care Changes due to LYNCH genetic testing. Provider based observational survey system on the health and well-being of patients and populations

Trial Locations

Locations (1)

DCABM; 🇺🇸 Land O' Lakes, Florida, United States